Skip to main content


Table 2 Biomarkers in the head and neck carcinoma

From: Perspectives in immunotherapy: meeting report from the “Immunotherapy Bridge”, Napoli, November 30th 2016

Biomarkers Prognostic Predictive
Epstein barr virus in endemic nasopharyngeal cancers Validated Validated
HPV Validated Potential
PET imaging post treatment Validated Potential
Hypoxia Potential Potential
EGFR (potential predictive factor for accelerated radiotherapy) Potential Not validated
TP53 gene mutation Potential Potential
Gene expression profiling Potential Potential
Immune checkpoint related Potential Potential